Editas Medicine (EDIT) Insider Trading & Ownership $2.20 -0.08 (-3.51%) Closing price 06/30/2025 04:00 PM EasternExtended Trading$2.20 +0.00 (+0.23%) As of 07:25 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Editas Medicine (NASDAQ:EDIT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.90%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$138.63K Get EDIT Insider Trade Alerts Want to know when executives and insiders are buying or selling Editas Medicine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EDIT Insider Buying and Selling by Quarter Editas Medicine Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/3/2025Amy ParisonCFOSell446$1.72$767.12 6/3/2025Gilmore Neil O'neillCEOSell15,192$1.72$26,130.24 6/3/2025Linda BurklyEVPSell726$1.72$1,248.72 12/3/2024Baisong MeiEVPSell541$2.08$1,125.28 12/3/2024Gilmore Neil O'neillCEOSell1,618$2.08$3,365.44 9/4/2024Baisong MeiEVPSell518$3.42$1,771.56 9/4/2024Gilmore Neil O'neillCEOSell1,555$3.42$5,318.10 7/25/2024Linda BurklyEVPSell11,886$5.42$64,422.12 7/19/2024Baisong MeiEVPSell6,619$5.21$34,484.99 (Data available from 1/1/2013 forward) EDIT Insider Trading Activity - Frequently Asked Questions Who is on Editas Medicine's Insider Roster? The list of insiders at Editas Medicine includes Amy Parison, Baisong Mei, Bruce Eaton, Gilmore Neil O'neill, Jessica Hopfield, Linda Burkly, Mark S Shearman, and Michelle Robertson. Learn more on insiders at EDIT. What percentage of Editas Medicine stock is owned by insiders? 1.90% of Editas Medicine stock is owned by insiders. Learn more on EDIT's insider holdings. Which Editas Medicine insiders have been buying company stock? The following insider purchased EDIT shares in the last 24 months: Jessica Hopfield ($253,800.00). How much insider buying is happening at Editas Medicine? Insiders have purchased a total of 45,000 EDIT shares in the last 24 months for a total of $253,800.00 bought. Which Editas Medicine insiders have been selling company stock? The following insiders have sold EDIT shares in the last 24 months: Amy Parison ($767.12), Baisong Mei ($269,662.27), Bruce Eaton ($10,411.93), Gilmore Neil O'neill ($834,966.36), and Linda Burkly ($65,670.84). How much insider selling is happening at Editas Medicine? Insiders have sold a total of 155,459 Editas Medicine shares in the last 24 months for a total of $1,181,478.52 sold. More Insider Trading Tools from MarketBeat Related Companies REPL Insider Ownership CRON Insider Ownership XERS Insider Ownership VIR Insider Ownership GYRE Insider Ownership NUVB Insider Ownership ANAB Insider Ownership PHAT Insider Ownership TRVI Insider Ownership SANA Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors?Insiders Chase Income and Stability in American Tower—Here’s Why3 Tech Stocks With High and Rising Institutional Interest3 Summer Stocks With Insider Buying and Analyst Support This page (NASDAQ:EDIT) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Editas Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Editas Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EDIT Stock Alerts